Dysregulation of IGF-1 and IL-15 highlights their crucial roles in maintaining muscle protein homeostasis and presents potential therapeutic targets for mitigating muscle atrophy in patients with COPD. The gene discussed is IL15; the disease is chronic obstructive pulmonary disease.